FDA Extends Type III Drug Master File E-Submission Compliance Date Another Year

Drug Industry Daily
A A
The FDA issued revised guidance on electronic submissions of drug master files, extending the timetable for Type III submissions by another year to May 5, 2020.

To View This Article:

Login

Subscribe To Drug Industry Daily